> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA OKs Bayer’s Ultravist for Mammography
- URL: https://www.fdaweb.com/fda-oks-bayers-ultravist-for-mammography/
- Published: 2023-06-26T12:00:00.000Z
- Updated: 2026-09-14T18:41:06.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5154760

FDA has approved Bayer’s Ultravist (iopromide)-300 and Ultravist-370, iodine-based contrast agents for contrast-enhanced mammography. The company says the products are intended to be used to visualize known or suspected breast lesions in adults, as an adjunct to mammography or ultrasound. Bayer says the indication “aligns with the recent increased focus on supplemental imaging needs for women at a higher risk for breast cancer, which may include the 40-50% of U.S. women older than 40 with dense breasts.”